title: Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity.
abstract: We report here on the in vitro and in silico characterization of the organization of the human complexin 2 (CPLX2) gene. This encodes for a protein of 134 amino acid residues, contains five exons, is localized on human chromosome 5q35.3, and spans more than 87 kb. We performed in silico analysis of the CPLX2 5' untranslated region (UTR) and propose an alternative variant of the gene transcript. Compared to the mRNA reported earlier [McMahon, H.T., Missler, M., Li, C., Sudhof, T.C., 1995. Complexins: cytosolic proteins that regulate SNAP receptor function. Cell 83, 111-119.], this transcript bears a partly altered 5'-UTR associated with the same open reading frame. Both CPLX2 transcripts share exons III-V; the alternative transcript is devoid of exons I and II, and includes exon A instead. Exon A is localized within CPLX2 intron 2 about 7 kb upstream to exon III. Using reverse transcription polymerase chain reaction (RT-PCR) we detected both types of transcripts in human brain mRNA. In silico data suggest that two putative alternative TATA-less promoter regions separated by 74 kb govern the expression of two CPLX2 transcripts. Several potential transcription start sites were detected by primer extension for each of two alternative CPLX2 transcripts. The relative abundance of the alternative transcripts was investigated in human and rat forebrain, cerebellum, and hippocampus. Whereas both transcripts were detected in human and rat brain, their expression levels were found to vary significantly among the regions investigated. The organization of CPLX2 transcripts is conserved in humans and rodents.
authors.affiliation: Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, 123182, Russia.
authors.forename: Natalja M
authors.initials: NM
authors.lastname: Raevskaya
authors.forename: Lyudmila V
authors.initials: LV
authors.lastname: Dergunova
authors.forename: Irina P
authors.initials: IP
authors.lastname: Vladychenskaya
authors.forename: Vasily V
authors.initials: VV
authors.lastname: Stavchansky
authors.forename: Maria V
authors.initials: MV
authors.lastname: Oborina
authors.forename: Andrey B
authors.initials: AB
authors.lastname: Poltaraus
authors.forename: Svetlana A
authors.initials: SA
authors.lastname: Limborska
mesh_terms: D020413:3' Untranslated Regions / Q000235:genetics; D020121:5' Untranslated Regions / Q000235:genetics; D033942:Adaptor Proteins, Vesicular Transport; D017398:Alternative Splicing; D000818:Animals; D001483:Base Sequence; D001921:Brain / Q000378:metabolism; D019295:Computational Biology; D017124:Conserved Sequence / Q000235:genetics; D018076:DNA, Complementary / Q000737:chemistry / Q000235:genetics; D019143:Evolution, Molecular; D005091:Exons; D020869:Gene Expression Profiling; D006801:Humans; D007438:Introns; D008297:Male; D051379:Mice; D008875:Middle Aged; D008969:Molecular Sequence Data; D009419:Nerve Tissue Proteins / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D016415:Sequence Alignment; D017422:Sequence Analysis, DNA; D024363:Transcription Initiation Site
chemical_list: D020413:3' Untranslated Regions; D020121:5' Untranslated Regions; D033942:Adaptor Proteins, Vesicular Transport; D018076:DNA, Complementary; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; C095993:complexin II